Title:
LSD1 INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2021/058024
Kind Code:
A1
Abstract:
Provided are a class of heterospirocyclic compound which act as a lysine-specific demethylase 1 (LSD1) inhibitor, and a use thereof in the preparation of a drug for treating diseases associated with LSD1. The heterospirocyclic compounds are compounds as shown in formula (I), and an isomer and pharmaceutically acceptable salt thereof.
More Like This:
| WO/2023/114954 | PYRAZOLOPYRAZINE COMPOUNDS AS SHP2 INHIBITORS |
| WO/1997/035862 | AZASPIRODERIVATIVES |
| JP2023549123 | PPARĪ³ modulator and usage method |
Inventors:
WU LINGYUN (CN)
ZHAN ZHEN (CN)
QIAN YI (CN)
WANG JUNWEI (CN)
CHEN SHUHUI (CN)
ZHAN ZHEN (CN)
QIAN YI (CN)
WANG JUNWEI (CN)
CHEN SHUHUI (CN)
Application Number:
PCT/CN2020/118824
Publication Date:
April 01, 2021
Filing Date:
September 29, 2020
Export Citation:
Assignee:
MEDSHINE DISCOVERY INC (CN)
International Classes:
C07D491/107; A61K31/13; A61K31/435; A61P35/00; C07C217/74; C07D205/04; C07D207/14
Domestic Patent References:
| WO2015123408A1 | 2015-08-20 | |||
| WO2019025588A1 | 2019-02-07 |
Foreign References:
| CN109153636A | 2019-01-04 | |||
| CN103857393A | 2014-06-11 | |||
| CN104203914A | 2014-12-10 | |||
| US20190211014A1 | 2019-07-11 |
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF: